In addition, by regulating the expression of the CD44 variant, ESRP1 can also influence critical signaling pathways such as PI3K/AKT and Wnt/β-catenin, thereby participating in the regulation of the tumor microenvironment (102, 103). This evidence concerns the gene CD44 and neoplasm.